nodes	percent_of_prediction	percent_of_DWPC	metapath
Naltrexone—UGT1A1—Etoposide—sarcoma	0.287	0.451	CbGbCtD
Naltrexone—ABCB1—Dactinomycin—sarcoma	0.101	0.159	CbGbCtD
Naltrexone—ABCB1—Mitoxantrone—sarcoma	0.0903	0.142	CbGbCtD
Naltrexone—ABCB1—Vincristine—sarcoma	0.0622	0.0977	CbGbCtD
Naltrexone—ABCB1—Etoposide—sarcoma	0.057	0.0895	CbGbCtD
Naltrexone—ABCB1—Doxorubicin—sarcoma	0.0389	0.061	CbGbCtD
Naltrexone—Naloxone—CREB1—sarcoma	0.0114	1	CrCbGaD
Naltrexone—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000454	0.00129	CcSEcCtD
Naltrexone—Hypersensitivity—Thiotepa—sarcoma	0.000453	0.00129	CcSEcCtD
Naltrexone—Nasopharyngitis—Epirubicin—sarcoma	0.000451	0.00128	CcSEcCtD
Naltrexone—Face oedema—Doxorubicin—sarcoma	0.00045	0.00128	CcSEcCtD
Naltrexone—Hypersensitivity—Dactinomycin—sarcoma	0.00045	0.00128	CcSEcCtD
Naltrexone—Gastrointestinal pain—Vincristine—sarcoma	0.000446	0.00127	CcSEcCtD
Naltrexone—Confusional state—Etoposide—sarcoma	0.000446	0.00127	CcSEcCtD
Naltrexone—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000445	0.00126	CcSEcCtD
Naltrexone—Anaphylactic shock—Etoposide—sarcoma	0.000442	0.00126	CcSEcCtD
Naltrexone—Asthenia—Thiotepa—sarcoma	0.000441	0.00125	CcSEcCtD
Naltrexone—Infection—Etoposide—sarcoma	0.000439	0.00125	CcSEcCtD
Naltrexone—Asthenia—Dactinomycin—sarcoma	0.000438	0.00124	CcSEcCtD
Naltrexone—Feeling abnormal—Mitoxantrone—sarcoma	0.000438	0.00124	CcSEcCtD
Naltrexone—Influenza—Epirubicin—sarcoma	0.000436	0.00124	CcSEcCtD
Naltrexone—Pruritus—Thiotepa—sarcoma	0.000435	0.00124	CcSEcCtD
Naltrexone—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000435	0.00123	CcSEcCtD
Naltrexone—Dehydration—Doxorubicin—sarcoma	0.000434	0.00123	CcSEcCtD
Naltrexone—Tachycardia—Etoposide—sarcoma	0.000431	0.00123	CcSEcCtD
Naltrexone—Body temperature increased—Vincristine—sarcoma	0.000431	0.00123	CcSEcCtD
Naltrexone—Abdominal pain—Vincristine—sarcoma	0.000431	0.00123	CcSEcCtD
Naltrexone—Skin disorder—Etoposide—sarcoma	0.000429	0.00122	CcSEcCtD
Naltrexone—Hyperhidrosis—Etoposide—sarcoma	0.000427	0.00121	CcSEcCtD
Naltrexone—Abdominal pain upper—Doxorubicin—sarcoma	0.000426	0.00121	CcSEcCtD
Naltrexone—Angina pectoris—Epirubicin—sarcoma	0.000424	0.00121	CcSEcCtD
Naltrexone—Urticaria—Mitoxantrone—sarcoma	0.000422	0.0012	CcSEcCtD
Naltrexone—Anorexia—Etoposide—sarcoma	0.000421	0.0012	CcSEcCtD
Naltrexone—Diarrhoea—Thiotepa—sarcoma	0.000421	0.0012	CcSEcCtD
Naltrexone—Body temperature increased—Mitoxantrone—sarcoma	0.00042	0.00119	CcSEcCtD
Naltrexone—Abdominal pain—Mitoxantrone—sarcoma	0.00042	0.00119	CcSEcCtD
Naltrexone—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.00042	0.00119	CcSEcCtD
Naltrexone—Bronchitis—Epirubicin—sarcoma	0.000419	0.00119	CcSEcCtD
Naltrexone—Diarrhoea—Dactinomycin—sarcoma	0.000418	0.00119	CcSEcCtD
Naltrexone—Nasopharyngitis—Doxorubicin—sarcoma	0.000417	0.00118	CcSEcCtD
Naltrexone—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000411	0.00117	CcSEcCtD
Naltrexone—Dizziness—Thiotepa—sarcoma	0.000407	0.00116	CcSEcCtD
Naltrexone—Upper respiratory tract infection—Epirubicin—sarcoma	0.000405	0.00115	CcSEcCtD
Naltrexone—Influenza—Doxorubicin—sarcoma	0.000403	0.00114	CcSEcCtD
Naltrexone—Hypersensitivity—Vincristine—sarcoma	0.000402	0.00114	CcSEcCtD
Naltrexone—Paraesthesia—Etoposide—sarcoma	0.000397	0.00113	CcSEcCtD
Naltrexone—Weight increased—Epirubicin—sarcoma	0.000397	0.00113	CcSEcCtD
Naltrexone—Weight decreased—Epirubicin—sarcoma	0.000394	0.00112	CcSEcCtD
Naltrexone—Dyspnoea—Etoposide—sarcoma	0.000394	0.00112	CcSEcCtD
Naltrexone—Somnolence—Etoposide—sarcoma	0.000393	0.00112	CcSEcCtD
Naltrexone—Angina pectoris—Doxorubicin—sarcoma	0.000393	0.00112	CcSEcCtD
Naltrexone—Hypersensitivity—Mitoxantrone—sarcoma	0.000391	0.00111	CcSEcCtD
Naltrexone—Asthenia—Vincristine—sarcoma	0.000391	0.00111	CcSEcCtD
Naltrexone—Vomiting—Thiotepa—sarcoma	0.000391	0.00111	CcSEcCtD
Naltrexone—Pneumonia—Epirubicin—sarcoma	0.000391	0.00111	CcSEcCtD
Naltrexone—Infestation NOS—Epirubicin—sarcoma	0.000388	0.0011	CcSEcCtD
Naltrexone—Infestation—Epirubicin—sarcoma	0.000388	0.0011	CcSEcCtD
Naltrexone—Vomiting—Dactinomycin—sarcoma	0.000388	0.0011	CcSEcCtD
Naltrexone—Rash—Thiotepa—sarcoma	0.000388	0.0011	CcSEcCtD
Naltrexone—Bronchitis—Doxorubicin—sarcoma	0.000388	0.0011	CcSEcCtD
Naltrexone—Dermatitis—Thiotepa—sarcoma	0.000388	0.0011	CcSEcCtD
Naltrexone—Headache—Thiotepa—sarcoma	0.000385	0.00109	CcSEcCtD
Naltrexone—Rash—Dactinomycin—sarcoma	0.000385	0.00109	CcSEcCtD
Naltrexone—Decreased appetite—Etoposide—sarcoma	0.000384	0.00109	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Etoposide—sarcoma	0.000382	0.00108	CcSEcCtD
Naltrexone—Asthenia—Mitoxantrone—sarcoma	0.000381	0.00108	CcSEcCtD
Naltrexone—Fatigue—Etoposide—sarcoma	0.000381	0.00108	CcSEcCtD
Naltrexone—Pain—Etoposide—sarcoma	0.000378	0.00107	CcSEcCtD
Naltrexone—Constipation—Etoposide—sarcoma	0.000378	0.00107	CcSEcCtD
Naltrexone—Conjunctivitis—Epirubicin—sarcoma	0.000378	0.00107	CcSEcCtD
Naltrexone—Urinary tract infection—Epirubicin—sarcoma	0.000378	0.00107	CcSEcCtD
Naltrexone—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000375	0.00106	CcSEcCtD
Naltrexone—Diarrhoea—Vincristine—sarcoma	0.000373	0.00106	CcSEcCtD
Naltrexone—Hepatobiliary disease—Epirubicin—sarcoma	0.000367	0.00104	CcSEcCtD
Naltrexone—Weight increased—Doxorubicin—sarcoma	0.000367	0.00104	CcSEcCtD
Naltrexone—Epistaxis—Epirubicin—sarcoma	0.000366	0.00104	CcSEcCtD
Naltrexone—Nausea—Thiotepa—sarcoma	0.000365	0.00104	CcSEcCtD
Naltrexone—Weight decreased—Doxorubicin—sarcoma	0.000365	0.00104	CcSEcCtD
Naltrexone—Sinusitis—Epirubicin—sarcoma	0.000364	0.00104	CcSEcCtD
Naltrexone—Feeling abnormal—Etoposide—sarcoma	0.000364	0.00103	CcSEcCtD
Naltrexone—Diarrhoea—Mitoxantrone—sarcoma	0.000364	0.00103	CcSEcCtD
Naltrexone—Nausea—Dactinomycin—sarcoma	0.000363	0.00103	CcSEcCtD
Naltrexone—Pneumonia—Doxorubicin—sarcoma	0.000362	0.00103	CcSEcCtD
Naltrexone—Gastrointestinal pain—Etoposide—sarcoma	0.000361	0.00103	CcSEcCtD
Naltrexone—Dizziness—Vincristine—sarcoma	0.000361	0.00102	CcSEcCtD
Naltrexone—Infestation NOS—Doxorubicin—sarcoma	0.000359	0.00102	CcSEcCtD
Naltrexone—Infestation—Doxorubicin—sarcoma	0.000359	0.00102	CcSEcCtD
Naltrexone—Urticaria—Etoposide—sarcoma	0.000351	0.000997	CcSEcCtD
Naltrexone—Body temperature increased—Etoposide—sarcoma	0.000349	0.000992	CcSEcCtD
Naltrexone—Abdominal pain—Etoposide—sarcoma	0.000349	0.000992	CcSEcCtD
Naltrexone—Urinary tract infection—Doxorubicin—sarcoma	0.000349	0.000992	CcSEcCtD
Naltrexone—Conjunctivitis—Doxorubicin—sarcoma	0.000349	0.000992	CcSEcCtD
Naltrexone—Hepatitis—Epirubicin—sarcoma	0.000349	0.000991	CcSEcCtD
Naltrexone—Vomiting—Vincristine—sarcoma	0.000347	0.000985	CcSEcCtD
Naltrexone—Pharyngitis—Epirubicin—sarcoma	0.000346	0.000983	CcSEcCtD
Naltrexone—Rash—Vincristine—sarcoma	0.000344	0.000977	CcSEcCtD
Naltrexone—Dermatitis—Vincristine—sarcoma	0.000344	0.000976	CcSEcCtD
Naltrexone—Connective tissue disorder—Epirubicin—sarcoma	0.000343	0.000973	CcSEcCtD
Naltrexone—Headache—Vincristine—sarcoma	0.000342	0.000971	CcSEcCtD
Naltrexone—Hepatobiliary disease—Doxorubicin—sarcoma	0.00034	0.000966	CcSEcCtD
Naltrexone—Epistaxis—Doxorubicin—sarcoma	0.000339	0.000963	CcSEcCtD
Naltrexone—Vomiting—Mitoxantrone—sarcoma	0.000338	0.00096	CcSEcCtD
Naltrexone—Sinusitis—Doxorubicin—sarcoma	0.000337	0.000958	CcSEcCtD
Naltrexone—Rash—Mitoxantrone—sarcoma	0.000335	0.000952	CcSEcCtD
Naltrexone—Dermatitis—Mitoxantrone—sarcoma	0.000335	0.000951	CcSEcCtD
Naltrexone—Headache—Mitoxantrone—sarcoma	0.000333	0.000945	CcSEcCtD
Naltrexone—Eye disorder—Epirubicin—sarcoma	0.000326	0.000926	CcSEcCtD
Naltrexone—Hypersensitivity—Etoposide—sarcoma	0.000326	0.000925	CcSEcCtD
Naltrexone—Tinnitus—Epirubicin—sarcoma	0.000325	0.000924	CcSEcCtD
Naltrexone—Nausea—Vincristine—sarcoma	0.000324	0.000921	CcSEcCtD
Naltrexone—Cardiac disorder—Epirubicin—sarcoma	0.000324	0.000919	CcSEcCtD
Naltrexone—Hepatitis—Doxorubicin—sarcoma	0.000323	0.000916	CcSEcCtD
Naltrexone—Pharyngitis—Doxorubicin—sarcoma	0.00032	0.00091	CcSEcCtD
Naltrexone—Asthenia—Etoposide—sarcoma	0.000317	0.000901	CcSEcCtD
Naltrexone—Connective tissue disorder—Doxorubicin—sarcoma	0.000317	0.000901	CcSEcCtD
Naltrexone—Angiopathy—Epirubicin—sarcoma	0.000316	0.000899	CcSEcCtD
Naltrexone—Nausea—Mitoxantrone—sarcoma	0.000316	0.000896	CcSEcCtD
Naltrexone—Immune system disorder—Epirubicin—sarcoma	0.000315	0.000895	CcSEcCtD
Naltrexone—Mediastinal disorder—Epirubicin—sarcoma	0.000314	0.000893	CcSEcCtD
Naltrexone—Chills—Epirubicin—sarcoma	0.000313	0.000889	CcSEcCtD
Naltrexone—Pruritus—Etoposide—sarcoma	0.000313	0.000888	CcSEcCtD
Naltrexone—Alopecia—Epirubicin—sarcoma	0.000308	0.000875	CcSEcCtD
Naltrexone—Mental disorder—Epirubicin—sarcoma	0.000306	0.000868	CcSEcCtD
Naltrexone—Malnutrition—Epirubicin—sarcoma	0.000304	0.000862	CcSEcCtD
Naltrexone—Diarrhoea—Etoposide—sarcoma	0.000302	0.000859	CcSEcCtD
Naltrexone—Eye disorder—Doxorubicin—sarcoma	0.000302	0.000856	CcSEcCtD
Naltrexone—Tinnitus—Doxorubicin—sarcoma	0.000301	0.000855	CcSEcCtD
Naltrexone—Cardiac disorder—Doxorubicin—sarcoma	0.000299	0.000851	CcSEcCtD
Naltrexone—Flatulence—Epirubicin—sarcoma	0.000299	0.00085	CcSEcCtD
Naltrexone—Tension—Epirubicin—sarcoma	0.000298	0.000846	CcSEcCtD
Naltrexone—Dysgeusia—Epirubicin—sarcoma	0.000297	0.000844	CcSEcCtD
Naltrexone—Nervousness—Epirubicin—sarcoma	0.000295	0.000837	CcSEcCtD
Naltrexone—Back pain—Epirubicin—sarcoma	0.000294	0.000834	CcSEcCtD
Naltrexone—Angiopathy—Doxorubicin—sarcoma	0.000293	0.000832	CcSEcCtD
Naltrexone—Dizziness—Etoposide—sarcoma	0.000292	0.00083	CcSEcCtD
Naltrexone—Muscle spasms—Epirubicin—sarcoma	0.000292	0.000829	CcSEcCtD
Naltrexone—Immune system disorder—Doxorubicin—sarcoma	0.000291	0.000828	CcSEcCtD
Naltrexone—Mediastinal disorder—Doxorubicin—sarcoma	0.000291	0.000826	CcSEcCtD
Naltrexone—Chills—Doxorubicin—sarcoma	0.00029	0.000822	CcSEcCtD
Naltrexone—Vision blurred—Epirubicin—sarcoma	0.000286	0.000813	CcSEcCtD
Naltrexone—Alopecia—Doxorubicin—sarcoma	0.000285	0.00081	CcSEcCtD
Naltrexone—Mental disorder—Doxorubicin—sarcoma	0.000283	0.000803	CcSEcCtD
Naltrexone—Ill-defined disorder—Epirubicin—sarcoma	0.000282	0.0008	CcSEcCtD
Naltrexone—Vomiting—Etoposide—sarcoma	0.000281	0.000798	CcSEcCtD
Naltrexone—Malnutrition—Doxorubicin—sarcoma	0.000281	0.000798	CcSEcCtD
Naltrexone—Agitation—Epirubicin—sarcoma	0.000279	0.000792	CcSEcCtD
Naltrexone—Rash—Etoposide—sarcoma	0.000279	0.000792	CcSEcCtD
Naltrexone—Dermatitis—Etoposide—sarcoma	0.000278	0.000791	CcSEcCtD
Naltrexone—Headache—Etoposide—sarcoma	0.000277	0.000786	CcSEcCtD
Naltrexone—Flatulence—Doxorubicin—sarcoma	0.000277	0.000786	CcSEcCtD
Naltrexone—Tension—Doxorubicin—sarcoma	0.000276	0.000783	CcSEcCtD
Naltrexone—Dysgeusia—Doxorubicin—sarcoma	0.000275	0.000781	CcSEcCtD
Naltrexone—Malaise—Epirubicin—sarcoma	0.000274	0.000778	CcSEcCtD
Naltrexone—Nervousness—Doxorubicin—sarcoma	0.000273	0.000775	CcSEcCtD
Naltrexone—Syncope—Epirubicin—sarcoma	0.000272	0.000773	CcSEcCtD
Naltrexone—Back pain—Doxorubicin—sarcoma	0.000272	0.000772	CcSEcCtD
Naltrexone—Muscle spasms—Doxorubicin—sarcoma	0.00027	0.000767	CcSEcCtD
Naltrexone—Palpitations—Epirubicin—sarcoma	0.000268	0.000762	CcSEcCtD
Naltrexone—Loss of consciousness—Epirubicin—sarcoma	0.000267	0.000758	CcSEcCtD
Naltrexone—Cough—Epirubicin—sarcoma	0.000265	0.000752	CcSEcCtD
Naltrexone—Vision blurred—Doxorubicin—sarcoma	0.000265	0.000752	CcSEcCtD
Naltrexone—Convulsion—Epirubicin—sarcoma	0.000263	0.000747	CcSEcCtD
Naltrexone—Nausea—Etoposide—sarcoma	0.000263	0.000746	CcSEcCtD
Naltrexone—Hypertension—Epirubicin—sarcoma	0.000262	0.000744	CcSEcCtD
Naltrexone—Ill-defined disorder—Doxorubicin—sarcoma	0.000261	0.00074	CcSEcCtD
Naltrexone—Chest pain—Epirubicin—sarcoma	0.000258	0.000734	CcSEcCtD
Naltrexone—Myalgia—Epirubicin—sarcoma	0.000258	0.000734	CcSEcCtD
Naltrexone—Arthralgia—Epirubicin—sarcoma	0.000258	0.000734	CcSEcCtD
Naltrexone—Agitation—Doxorubicin—sarcoma	0.000258	0.000733	CcSEcCtD
Naltrexone—Anxiety—Epirubicin—sarcoma	0.000258	0.000732	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000257	0.000729	CcSEcCtD
Naltrexone—Discomfort—Epirubicin—sarcoma	0.000255	0.000725	CcSEcCtD
Naltrexone—Malaise—Doxorubicin—sarcoma	0.000253	0.000719	CcSEcCtD
Naltrexone—Dry mouth—Epirubicin—sarcoma	0.000253	0.000718	CcSEcCtD
Naltrexone—Syncope—Doxorubicin—sarcoma	0.000252	0.000715	CcSEcCtD
Naltrexone—Confusional state—Epirubicin—sarcoma	0.00025	0.00071	CcSEcCtD
Naltrexone—Palpitations—Doxorubicin—sarcoma	0.000248	0.000705	CcSEcCtD
Naltrexone—Oedema—Epirubicin—sarcoma	0.000248	0.000704	CcSEcCtD
Naltrexone—Anaphylactic shock—Epirubicin—sarcoma	0.000248	0.000704	CcSEcCtD
Naltrexone—Loss of consciousness—Doxorubicin—sarcoma	0.000247	0.000701	CcSEcCtD
Naltrexone—Infection—Epirubicin—sarcoma	0.000246	0.000699	CcSEcCtD
Naltrexone—Cough—Doxorubicin—sarcoma	0.000245	0.000696	CcSEcCtD
Naltrexone—Shock—Epirubicin—sarcoma	0.000244	0.000692	CcSEcCtD
Naltrexone—Convulsion—Doxorubicin—sarcoma	0.000243	0.000691	CcSEcCtD
Naltrexone—Nervous system disorder—Epirubicin—sarcoma	0.000243	0.00069	CcSEcCtD
Naltrexone—Hypertension—Doxorubicin—sarcoma	0.000243	0.000689	CcSEcCtD
Naltrexone—Tachycardia—Epirubicin—sarcoma	0.000242	0.000687	CcSEcCtD
Naltrexone—Skin disorder—Epirubicin—sarcoma	0.000241	0.000684	CcSEcCtD
Naltrexone—Hyperhidrosis—Epirubicin—sarcoma	0.00024	0.00068	CcSEcCtD
Naltrexone—Arthralgia—Doxorubicin—sarcoma	0.000239	0.000679	CcSEcCtD
Naltrexone—Chest pain—Doxorubicin—sarcoma	0.000239	0.000679	CcSEcCtD
Naltrexone—Myalgia—Doxorubicin—sarcoma	0.000239	0.000679	CcSEcCtD
Naltrexone—Anxiety—Doxorubicin—sarcoma	0.000238	0.000677	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000237	0.000675	CcSEcCtD
Naltrexone—Discomfort—Doxorubicin—sarcoma	0.000236	0.000671	CcSEcCtD
Naltrexone—Anorexia—Epirubicin—sarcoma	0.000236	0.000671	CcSEcCtD
Naltrexone—Dry mouth—Doxorubicin—sarcoma	0.000234	0.000664	CcSEcCtD
Naltrexone—Confusional state—Doxorubicin—sarcoma	0.000231	0.000657	CcSEcCtD
Naltrexone—Oedema—Doxorubicin—sarcoma	0.000229	0.000651	CcSEcCtD
Naltrexone—Anaphylactic shock—Doxorubicin—sarcoma	0.000229	0.000651	CcSEcCtD
Naltrexone—Infection—Doxorubicin—sarcoma	0.000228	0.000647	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000226	0.000641	CcSEcCtD
Naltrexone—Shock—Doxorubicin—sarcoma	0.000226	0.000641	CcSEcCtD
Naltrexone—Nervous system disorder—Doxorubicin—sarcoma	0.000225	0.000639	CcSEcCtD
Naltrexone—Insomnia—Epirubicin—sarcoma	0.000224	0.000636	CcSEcCtD
Naltrexone—Tachycardia—Doxorubicin—sarcoma	0.000224	0.000635	CcSEcCtD
Naltrexone—Skin disorder—Doxorubicin—sarcoma	0.000223	0.000632	CcSEcCtD
Naltrexone—Paraesthesia—Epirubicin—sarcoma	0.000222	0.000632	CcSEcCtD
Naltrexone—Hyperhidrosis—Doxorubicin—sarcoma	0.000222	0.000629	CcSEcCtD
Naltrexone—Dyspnoea—Epirubicin—sarcoma	0.000221	0.000627	CcSEcCtD
Naltrexone—Somnolence—Epirubicin—sarcoma	0.00022	0.000626	CcSEcCtD
Naltrexone—Anorexia—Doxorubicin—sarcoma	0.000219	0.000621	CcSEcCtD
Naltrexone—Decreased appetite—Epirubicin—sarcoma	0.000215	0.000612	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Epirubicin—sarcoma	0.000214	0.000608	CcSEcCtD
Naltrexone—Fatigue—Epirubicin—sarcoma	0.000214	0.000607	CcSEcCtD
Naltrexone—Pain—Epirubicin—sarcoma	0.000212	0.000602	CcSEcCtD
Naltrexone—Constipation—Epirubicin—sarcoma	0.000212	0.000602	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000209	0.000593	CcSEcCtD
Naltrexone—Insomnia—Doxorubicin—sarcoma	0.000207	0.000589	CcSEcCtD
Naltrexone—Paraesthesia—Doxorubicin—sarcoma	0.000206	0.000585	CcSEcCtD
Naltrexone—Dyspnoea—Doxorubicin—sarcoma	0.000204	0.000581	CcSEcCtD
Naltrexone—Feeling abnormal—Epirubicin—sarcoma	0.000204	0.00058	CcSEcCtD
Naltrexone—Somnolence—Doxorubicin—sarcoma	0.000204	0.000579	CcSEcCtD
Naltrexone—Gastrointestinal pain—Epirubicin—sarcoma	0.000203	0.000575	CcSEcCtD
Naltrexone—Decreased appetite—Doxorubicin—sarcoma	0.000199	0.000566	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000198	0.000562	CcSEcCtD
Naltrexone—Fatigue—Doxorubicin—sarcoma	0.000198	0.000561	CcSEcCtD
Naltrexone—Urticaria—Epirubicin—sarcoma	0.000197	0.000559	CcSEcCtD
Naltrexone—Pain—Doxorubicin—sarcoma	0.000196	0.000557	CcSEcCtD
Naltrexone—Constipation—Doxorubicin—sarcoma	0.000196	0.000557	CcSEcCtD
Naltrexone—Body temperature increased—Epirubicin—sarcoma	0.000196	0.000556	CcSEcCtD
Naltrexone—Abdominal pain—Epirubicin—sarcoma	0.000196	0.000556	CcSEcCtD
Naltrexone—Feeling abnormal—Doxorubicin—sarcoma	0.000189	0.000537	CcSEcCtD
Naltrexone—Gastrointestinal pain—Doxorubicin—sarcoma	0.000187	0.000532	CcSEcCtD
Naltrexone—Hypersensitivity—Epirubicin—sarcoma	0.000183	0.000518	CcSEcCtD
Naltrexone—Urticaria—Doxorubicin—sarcoma	0.000182	0.000517	CcSEcCtD
Naltrexone—Abdominal pain—Doxorubicin—sarcoma	0.000181	0.000515	CcSEcCtD
Naltrexone—Body temperature increased—Doxorubicin—sarcoma	0.000181	0.000515	CcSEcCtD
Naltrexone—Asthenia—Epirubicin—sarcoma	0.000178	0.000505	CcSEcCtD
Naltrexone—Pruritus—Epirubicin—sarcoma	0.000175	0.000498	CcSEcCtD
Naltrexone—Diarrhoea—Epirubicin—sarcoma	0.00017	0.000481	CcSEcCtD
Naltrexone—Hypersensitivity—Doxorubicin—sarcoma	0.000169	0.00048	CcSEcCtD
Naltrexone—Asthenia—Doxorubicin—sarcoma	0.000164	0.000467	CcSEcCtD
Naltrexone—Dizziness—Epirubicin—sarcoma	0.000164	0.000465	CcSEcCtD
Naltrexone—Pruritus—Doxorubicin—sarcoma	0.000162	0.000461	CcSEcCtD
Naltrexone—Vomiting—Epirubicin—sarcoma	0.000158	0.000447	CcSEcCtD
Naltrexone—Diarrhoea—Doxorubicin—sarcoma	0.000157	0.000446	CcSEcCtD
Naltrexone—Rash—Epirubicin—sarcoma	0.000156	0.000444	CcSEcCtD
Naltrexone—Dermatitis—Epirubicin—sarcoma	0.000156	0.000443	CcSEcCtD
Naltrexone—Headache—Epirubicin—sarcoma	0.000155	0.000441	CcSEcCtD
Naltrexone—Dizziness—Doxorubicin—sarcoma	0.000152	0.000431	CcSEcCtD
Naltrexone—Nausea—Epirubicin—sarcoma	0.000147	0.000418	CcSEcCtD
Naltrexone—Vomiting—Doxorubicin—sarcoma	0.000146	0.000414	CcSEcCtD
Naltrexone—Rash—Doxorubicin—sarcoma	0.000145	0.000411	CcSEcCtD
Naltrexone—Dermatitis—Doxorubicin—sarcoma	0.000144	0.00041	CcSEcCtD
Naltrexone—Headache—Doxorubicin—sarcoma	0.000144	0.000408	CcSEcCtD
Naltrexone—Nausea—Doxorubicin—sarcoma	0.000136	0.000387	CcSEcCtD
